Palisade Bio Inc (NASDAQ:PALI) currently has a daily average trading volume of 1.61M but it saw 10191788 shares traded in last market. With a market cap of 2.90M USD, the company’s current market price of $1.05 came rising about 11.70 while comparing to the previous closing price of $0.94. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.65 and as low as $0.75. In the recent trading on the day, stock has struck highest price mark of $0.8062 while lowest mark touched by it was $1.09.
Taking a look at 20-day trading activity of Palisade Bio Inc (PALI) gives us an average price of $0.9148, while its current price level is -89.12% below from 52-week high level whereas it is 40.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.3186 while that of 200 days or SMA-200 reads an average of $2.9595. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.93% during that period while stretching the period over a month that decreases to 9.52%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 51.03 which implies that the stock is in neutral territory.
Over the week, PALI’s stock price is moving 27.50% up while it is -9.48% when we observe its performance for the past one month. Year-to-date it is -36.36% down and over the past year, the stock is showing a downside performance of -81.87%.
The company is expected to be releasing its next quarterly report on 2024-Nov-11, for which analysts forecasted an EPS of -1.99 while estimate for next year EPS is -11.66.
Currently, Palisade Bio Inc’s total number of outstanding shares is 2.77M with 0.80% of that held by the insiders while 7.20% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -212.85% and return on equity (ROE) at -135.96%. Stock’s beta reads 1.32. Stock has a price to book (P/B) ratio of 0.19. Its return on asset (ROA) is -106.54% on average.
